What is the recommended treatment for acute coronary syndrome in a patient using cocaine?

Treatment of Acute Coronary Syndrome in Cocaine Use

Treat cocaine-associated ACS with standard ACS protocols (aspirin, anticoagulation, reperfusion), but absolutely avoid beta-blockers during acute intoxication and prioritize benzodiazepines plus nitroglycerin for initial symptom control. 1

Initial Management Based on Intoxication Status

Acutely Intoxicated Patients (euphoria, tachycardia, hypertension present)

First-line therapy:

• Benzodiazepines (e.g., lorazepam 1-2 mg IV) alone or combined with nitroglycerin for hypertension and tachycardia 1, 2
• This combination is superior to nitroglycerin alone, with significantly greater pain relief at 5 and 10 minutes (p=0.02 and p=0.005) 2
• Absolutely contraindicated: Beta-blockers - they cause unopposed alpha-stimulation and worsen coronary vasospasm 1

Non-Intoxicated Patients (recent use but no acute intoxication signs)

Treat identically to standard ACS:

• Standard antiplatelet therapy (aspirin, P2Y12 inhibitors)
• Anticoagulation (unfractionated heparin or LMWH)
• Beta-blockers are safe once acute intoxication has resolved 1

ST-Elevation MI Management

Immediate reperfusion strategy:

1. Administer sublingual nitroglycerin or IV calcium channel blocker (diltiazem 20 mg IV) 3, 4

2. If no response: Proceed directly to coronary angiography (preferred over fibrinolysis) 3, 4

3. PCI is preferred over fibrinolysis because:

   • Cocaine users frequently have contraindications to fibrinolysis (hypertension, seizures, aortic dissection)
   • Better outcomes with mechanical intervention 3

4. If PCI performed: Use bare-metal stents preferentially over drug-eluting stents

   • Cocaine users are unreliable with prolonged dual antiplatelet therapy
   • Bare-metal stents require shorter duration of dual antiplatelet therapy
   • Reduces risk of catastrophic in-stent thrombosis 3

5. Fibrinolysis only if:

   • ST-elevation persists after nitroglycerin and calcium channel blockers
   • No contraindications present
   • Coronary angiography unavailable 3, 4

Non-ST-Elevation ACS Management

Observation and biomarker protocol:

• Draw cardiac troponin (preferred over CK-MB due to skeletal muscle injury from cocaine) at presentation and 6-hour intervals 3
• If ECG shows ST-changes but negative biomarkers: 24-hour monitored observation (most complications occur within 24 hours) 3
• Alternative validated approach: 9-12 hour observation with troponin at 3,6, and 9 hours 3
• If unchanged after observation period: safe for discharge 3

Medication Algorithm

Step 1: Benzodiazepines + Nitroglycerin

• Addresses sympathetic hyperactivity and vasospasm
• Safe and effective first-line 1, 2

Step 2: If inadequate response, add Calcium Channel Blockers

• Verapamil or diltiazem (NOT short-acting nifedipine)
• Avoid in heart failure or left ventricular dysfunction
• Not first-line but reasonable second-line 3, 5

Step 3: Consider Phentolamine (alpha-blocker)

• For refractory vasospasm unresponsive to above measures
• Reverses cocaine-induced coronary vasoconstriction 5, 6
• Limited evidence but biologically sound

Step 4: Standard ACS medications

• Aspirin (unless true allergy)
• Anticoagulation (UFH or LMWH)
• Morphine for pain (titrated IV)
• Clopidogrel or other P2Y12 inhibitors 3, 7, 5

Critical Pitfalls to Avoid

1. Beta-blocker administration during acute intoxication - causes unopposed alpha-stimulation and paradoxical worsening of coronary spasm 1

2. Relying on CK-MB alone - cocaine causes rhabdomyolysis and skeletal muscle injury; use troponin I or T 3

3. Drug-eluting stents in active cocaine users - high risk of non-adherence to dual antiplatelet therapy and subsequent stent thrombosis 3

4. Premature discharge - only 6% develop MI, but complications occur within 24 hours; adequate observation is essential 3

5. Missing aortic or coronary dissection - reported complications of cocaine use that contraindicate fibrinolysis 3

Key Pathophysiology Considerations

Cocaine causes ACS through multiple mechanisms:

• Direct coronary vasospasm (alpha-adrenergic stimulation)
• Increased myocardial oxygen demand (tachycardia, hypertension, increased contractility)
• Enhanced platelet aggregation and thrombosis
• Accelerated atherosclerosis with chronic use
• Endothelial dysfunction 1

The treatment strategy must address both the acute sympathetic crisis and the underlying ischemic process, which is why benzodiazepines combined with vasodilators form the cornerstone of initial management.